Australia - English - Department of Health (Therapeutic Goods Administration)

juno pharmaceuticals pty ltd - phenytoin sodium, quantity: 250 mg - injection, solution - excipient ingredients: sodium hydroxide; water for injections; ethanol; propylene glycol - control of status epilepticus, tonic-clonic (grand mal), psychomotor seizures and the prevention of seizures occuring during or following neurosurgery. phenytoin will prevent or effectively decrease the incidence and severity of convulvsive seizures in a high percentage of cases, with patients exhibiting little tendency to become resistant to its action. besides its effectiveness in controlling seizures, phenytoin frequently improves the mental condition and outlook of epileptic patients. it has also been used in the treatment of certain cardiac arrhythmias, particularly in those patients who do not respond to convential antiarrhythmic agents or to cardioversion. phenytoin serum level determinations may be necessary for optimal dosage adjustments (see dosage and administation).

Australia - English - Department of Health (Therapeutic Goods Administration)

link medical products pty ltd t/a link pharmaceuticals - primidone, quantity: 250 mg - tablet, uncoated - excipient ingredients: carmellose calcium; povidone; gelatin; magnesium stearate; stearic acid - management of grand mal and psychomotor (temporal lobe) epilepsy. it is also of value in the management of focal or jacksonian seizures, myoclonic jerks and akinetic attacks.

New Zealand - English - Medsafe (Medicines Safety Authority)

clinect nz pty limited - primidone 250mg - tablet - 250 mg - active: primidone 250mg excipient: colloidal silicon dioxide croscarmellose sodium magnesium stearate methylcellulose - indicated for the management of grand mal epilepsy

New Zealand - English - Medsafe (Medicines Safety Authority)

novartis new zealand ltd - phenytoin sodium 50 mg/ml - solution for injection - 50 mg/ml - active: phenytoin sodium 50 mg/ml excipient: ethanol propylene glycol sodium hydroxide water for injection

New Zealand - English - Medsafe (Medicines Safety Authority)

roche products (nz) ltd - vemurafenib 240mg (as a co-precipitate with hypromellose acetate succinate (800 mg total));  ;   - film coated tablet - 240 mg - active: vemurafenib 240mg (as a co-precipitate with hypromellose acetate succinate (800 mg total))     excipient: colloidal silicon dioxide croscarmellose sodium hyprolose iron oxide red macrogol 3350 magnesium stearate polyvinyl alcohol purified talc titanium dioxide - indicated for the treatment of unresectable stage iiic or stage iv metastatic melanoma positive for the braf v600 mutation.

Israel - English - Ministry of Health

roche pharmaceuticals (israel) ltd - vemurafenib - film coated tablets - vemurafenib 240 mg - vemurafenib - vemurafenib - zelboraf is indicated for the treatment of brafv600 mutation-positive unresectable or metastatic melanoma.

Israel - English - Ministry of Health

rekah pharmaceutical industry ltd, israel - primidone - tablets - primidone 250 mg - primidone - primidone - anticonvulsant.

Ireland - English - HPRA (Health Products Regulatory Authority)

pfizer healthcare ireland - phenytoin sodium - capsule, hard - 50 milligram(s) - hydantoin derivatives; phenytoin

Ireland - English - HPRA (Health Products Regulatory Authority)

pfizer healthcare ireland - phenytoin sodium - capsule, hard - 300 milligram(s) - hydantoin derivatives; phenytoin

Ireland - English - HPRA (Health Products Regulatory Authority)

ltt pharma limited - phenytoin sodium - capsules hard - 100 milligram